MycologyFungal Cell Biology: Candida albicans Pathogenesis

Fungal Cell Biology: Candida albicans Pathogenesis

Concept Name

Candida albicans Pathogenesis

Genetic Loci

EFG1 (enhanced filamentous growth) regulates yeast‑to‑hyphal transition. SAP gene family (secreted aspartyl proteinases) facilitates tissue invasion. ERG11 encodes lanosterol 14α‑demethylase – target of azoles.

Intracellular Cascade

Environmental cues (pH, temperature, serum) → Ras‑cAMP‑PKA pathway → activation of Efg1 → hyphal morphogenesis. Adhesins (Als family) mediate adhesion to host cells. Biofilm formation via quorum sensing (farnesol/tyrosol).

Required Cofactors

Iron is essential for growth; Candida uses iron‑acquisition systems (hemoglobin receptors, siderophores). Zinc is required for secreted aspartyl proteinase activity.

Histology Stains

PAS (Periodic Acid‑Schiff) and GMS (Gomori Methenamine Silver) stain fungal cell walls magenta‑red or black, respectively. Mucicarmine stains Cryptococcus capsule but not Candida.

EM Findings

Yeast cells show a thick cell wall (100‑200 nm) composed of mannoproteins, β‑glucans, and chitin. Hyphae have parallel cell walls with septa at regular intervals.

Knockout Phenotype

Deletion of EFG1 in C. albicans abolishes hyphal formation and significantly attenuates virulence in a murine model of disseminated candidiasis.

Specific Toxins

Azole antifungals (Fluconazole) inhibit Erg11, blocking ergosterol synthesis. Echinocandins (Caspofungin) inhibit β‑1,3‑glucan synthase. Amphotericin B binds ergosterol, forming membrane pores.

Personal Clinical Notes